Sunesis Pharmaceuticals Non-Employee Director Compensation Policy
Sunesis Pharmaceuticals, Inc. has set an annual compensation policy for its non-employee board members. Each receives a base cash payment of $40,000, with additional payments for serving as chair or member of various board committees. Non-employee directors are also reimbursed for expenses related to board and committee meetings. Equity compensation includes an initial grant of 75,000 stock options and an annual grant of 40,000 stock options. This policy outlines the compensation structure and benefits for non-employee directors of the company.
Exhibit 10.1
Non-Employee Director Compensation Information
Sunesis Pharmaceuticals, Inc. has established the following annual compensation for non-employee members of its board of directors as follows.
Cash Compensation:
Board member: $40,000
In addition, each non-employee member of the board of directors is eligible to receive:
Board Chair: $20,000
Audit Committee Chair: $20,000
Compensation Committee Chair: $15,000
Nominating Committee Chair: $7,500
Audit Committee member: $10,000
Compensation Committee member: $7,500
Nominating Committee member: $5,000
In addition, all non-employee directors are reimbursed for out-of-pocket expenses incurred in attending board of directors and committee meetings.
Equity Compensation:
Initial Grant—Number of options to purchase shares of common stock: 75,000
Annual Grant—Number of options to purchase shares of common stock: 40,000
